Department of Respiratory Oncology

Guangxi Medical University Cancer Hospital, Nanning
呼吸肿瘤内科 · Medical Oncology

The Department of Respiratory Oncology, also known as the Second Chemotherapy Department, focuses on clinical care, teaching, and research. It primarily treats chest tumors, including non-small cell lung cancer, small cell lung cancer, malignant pleural mesothelioma, and mediastinal malignancies. The team also has extensive experience in chemotherapy for lymphoma, breast cancer, liver cancer, gastric cancer, and colorectal cancer. Treatment methods include chemotherapy drugs and molecular targeted therapy. The department performs EGFR and ALK driver gene testing to support standardized, precise, and individualized treatment plans for lung cancer patients.

What the department treats

Key facts

As described by the hospital.

Team

5 doctors listed, including 3 chief physicians. Its chief physicians have 2 first- or senior-author papers on PubMed since 2016.

Chief physicianClinical focusKey papers since 2016
Dr. Qitao Yu
于起涛
Diagnosis and chemotherapy for malignancies, including liver, breast, lung, lymphoma, nasopharyngeal, and gastrointestinal cancers.1
Dr. Ruiling Ning
宁瑞玲
Diagnosis and comprehensive treatment of thoracic tumors, with a focus on lung cancer.1
Dr. Aiping Zeng
曾爱屏
Diagnosis and treatment of common lung diseases and complex cases, with a focus on early detection of chest tumors and lung cancer, chemotherapy, and multidisciplinary comprehensive care.0

Associate chief physicians

We are an independent coordination service, not part of this hospital. Team data comes from public doctor-listing platforms; publication counts come from PubMed, matched by full name and affiliation, and doctors with very common names are checked by hand before their papers are shown. How we build this directory.

Not sure which specialist is right?

Send your records. We find a specialist in the right field to review your case and write a treatment plan with a cost estimate.

Get a specialist opinion